 ROCKVILLE, MD, May 19, 2021 GLOBE NEWSWIRE -- MacroGenics, Inc. Nasdaq: MGNX, a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Companys management will participate in Cowens 2nd Annual Virtual Oncology Innovation Summit. MacroGenics management will participate in a fireside chat with the analyst on Thursday, May 20, 2021, at 9:20 am ET. 